MedPath

Efficacy and Safety of Shen Que (RN8) Moxibustion in Unexpected POR

Not Applicable
Completed
Conditions
Infertility
Interventions
Other: Shen Que Moxibustion
Registration Number
NCT05653557
Lead Sponsor
Shandong University of Traditional Chinese Medicine
Brief Summary

Moxibustion of Shen Que (RN8) can increase the number of embryos available for transfer, thus improving pregnancy outcomes in women of advanced reproductive age who experience unexpected poor ovarian response.

Detailed Description

According to the traditional Chinese medicine (TCM) theory, Shen Que (RN8) is the place where the vitality converges under the navel, and is closely connected with the vitality generated by the kidney Qi. Therefore, stimulating Shen Que may stimulate the essence stored in the kidney, and improve the fertility of "五七" (≥ 35 years old) women.

Shen Que moxibustion has been shown to improve ovarian functional reserve in patients with ovarian insufficiency in previous studies. Nevertheless, studies on Shen Que moxibustion in advanced women with unexpected poor ovarian response (POR) who undergo IVF-ET are very limited. Consequently, we designed this randomized controlled trial to validate the hypothesis that Shen Que moxibustion improves reproductive outcomes in unexpected POR women.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • ≥35 years old with normal pre-stimulation ovarian reserve parameters (antral follicle count (AFC) ≥ 5 or anti-mullerian hormone (AMH) ≥1.2 ng/ml) and with an expected poor ovarian response (fewer than 4 oocytes) after standard ovarian stimulation.
Exclusion Criteria
  • Individuals with a Body Mass Index (BMI) ≥ 35 Kg/m2
  • Those using the natural cycle or mild stimulation for IVF/intracytoplasmic sperm injection (ICSI) treatment
  • Those with a history of unilateral oophorectomy or recurrent pregnancy loss, defined as two or more spontaneous abortions
  • Acceptors of donated oocytes or performed either In vitro Maturation (IVM) or blastocyst biopsy for Preimplantation Genetic Diagnosis (PGD) or Preimplantation Genetic Testing for Aneuploidies (PGT-A)
  • Those previously diagnosed with congenital (e.g., mediastinal uterus and double uterus) or acquired (e.g., submucosal myoma and adenomyosis) uterine abnormalities
  • Patients with extremely advanced age ( ≥ 45 years old)
  • Presence of a non-surgically treated hydrosalpinx or endometrial polyp and an ovarian endometriosis cyst requiring surgery, during ovarian stimulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Shen Que Moxibustion groupShen Que Moxibustion-
Primary Outcome Measures
NameTimeMethod
Number of oocytes retrievedOne month

Number of oocytes retrieved

Secondary Outcome Measures
NameTimeMethod
Cumulative Clinical pregnancy rateFourteen months

Clinic pregnancy will be diagnosed with the detection of an intrauterine gestation sac. And cumulative clinic pregnancy rate is calculated by the number of women who achieves clinical pregnancy after transfers of all study-specific embryos (within 1 year after randomization) by the total number of women randomized to the specific group.

Cumulative live birth rateEighteen months

Cumulative live birth rates (CLBR), defined as the proportion of deliveries with at least one live birth per started cycle or per oocyte aspiration, including all fresh and/or frozen embryo transfers until one delivery with a live birth or until all embryos were used.

Cycle cancellation rateOne month

Cycle cancellation is defined as cycle cancelled before obtaining at least one viable embryo for any reason. And cycle cancellation rate is calculated by dividing the number of women cancelled their cycle before obtaining at least one viable embryo for any reason by the total number of women randomized to the specific group.

Implantation rateFourteen months

Number of gestation sac detected / number of embryo transferred.

Good quality embryo rateOne month

Good quality embryo is defined as embryo that is graded as 6-cell grade 2 (6CII) or better or blastocyst. And good quality embryo rate is calculated by dividing the number of good quality embryo by the total number of embryo obtained after fertilization in the specific group.

Number of Metaphase II (MII) eggsOne month

MII eggs is defined as eggs retrieved that reach the MII phase.

Trial Locations

Locations (1)

The Affiliated Hospital of Shandong University of Traditional Chinese Medicine

🇨🇳

Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath